TY - JOUR
T1 - Clinical evaluation of roxithromycin in patients with acne
AU - Akamatsu, H.
AU - Nishijima, S.
AU - Akamatsu, M.
AU - Kurokawa, I.
AU - Asada, Y.
PY - 1996
Y1 - 1996
N2 - On the basis of reports that erythromycin is effective in the treatment of acne, we investigated whether roxithromycin (ROM), a new derivative of erythromycin, might also be effective in treating acne. Roxithromycin was administered to 30 patients with acne for 8 weeks. General improvement was assessed 8 weeks after the initiation of the therapy with a six-graded scale as follows; 1: good improvement, 2: moderate improvement, 3: slight improvement, 4: no change, 5: worsening, and 6: no assessment. The percentage of good or moderate improvement was 73.3%, and that of good improvement alone was 20.0%. Our results suggest that ROM is effective in the treatment of acne.
AB - On the basis of reports that erythromycin is effective in the treatment of acne, we investigated whether roxithromycin (ROM), a new derivative of erythromycin, might also be effective in treating acne. Roxithromycin was administered to 30 patients with acne for 8 weeks. General improvement was assessed 8 weeks after the initiation of the therapy with a six-graded scale as follows; 1: good improvement, 2: moderate improvement, 3: slight improvement, 4: no change, 5: worsening, and 6: no assessment. The percentage of good or moderate improvement was 73.3%, and that of good improvement alone was 20.0%. Our results suggest that ROM is effective in the treatment of acne.
UR - http://www.scopus.com/inward/record.url?scp=0030066335&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030066335&partnerID=8YFLogxK
U2 - 10.1177/030006059602400114
DO - 10.1177/030006059602400114
M3 - Article
C2 - 8674787
AN - SCOPUS:0030066335
SN - 0300-0605
VL - 24
SP - 109
EP - 114
JO - Journal of International Medical Research
JF - Journal of International Medical Research
IS - 1
ER -